Do you have lupus? We want to learn if Mycophenolate Mofetil (MMF) and voclospoporin medications used in this study are the same or better at treating lupus outside the kidney (SLE)

Do you have systemic lupus erythematosus (SLE)? If your lupus is active and your medications have been stable, you may be able to take part in a research study. This study includes one infusion of stem cells or a placebo and then about a year of safety follow-up visits.

Do you have T2DM? Are you concerned about your heart health? If you are also overweight or obese, you may be able to take part in a study where we are comparing insulin to a new oral medication to help better control diabetes, heart health, and weight loss. All current diabetes medications and study product will be paid for by the study. Compensation and diabetes care and counseling provided.

Do you want to help in the design of a new device that can electronically measure and track your strength? We are testing a new system that uses an electronic resistance exercise band and an 'app' designed for older adults to improve strength and prevent weakness. If you have an interest, you may be able to share your opinions on the device with us! We will provide $50 in gas card incentives.

People with kidney disease that have the APOL1 risk variant are at a greater risk for developing protein in their urine and chronic kidney disease. This research study is being done to determine if the investigational drug, VX-147 can slow or stop the worsening of kidney function as well as target the underlying cause of kidney disease.

Does your child have frequently relapsing or steroid dependent nephrotic syndrome? This study is testing a medicine called obinutuzumab, and comparing it with another one, mycophenolate mofetil (MMF), to see which works better for children with nephrotic syndrome.

Do you have Alpha-1 antitrypsin deficiency?

Are you a generally healthy person? If so, you may able to participate in a research study to find out more about the things that affect lung function and the risk of future lung disease.

The purpose of the EPPIK study is to gain further experience on the use of sparsentan in children.

We still have a lot to learn about why people develop glomerular disease and what the best medicines are to treat these diseases. Diabetes is a common, chronic illness and many people with glomerular disease also have diabetes. Currently, there is no information telling us the best ways to treat patients with both diabetes and glomerular disease, or how to counsel them about prognosis and risks for complications. This substudy of the Cure Glomerulopathy Network brings together information and laboratory specimens from patients with diabetes and glomerular disease to speed up and improve health research for their care.